Gemini Therapeutics, Inc. ($GMTX)
Filing Information
| Accession Number | 0001193125-26-018320 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
3,000
Total Value
$83,240.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Jan 20, 2026 | Exercise/Conversion | 1,000 | $13.50 | $13,500.00 | 38,793 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 20, 2026 | Sale | 1,000 | $69.74 | $69,740.00 | 37,793 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Jan 20, 2026 | Exercise/Conversion | 1,000 | $0.00 | $0.00 | 21,270 | Direct | โ | View Details |